Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-6956

CMS117 should include PCV20

XMLWordPrintable

    • Icon: Other Other
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Hide
      Thank you for your inquiry regarding CMS117v12 (Childhood Immunization Status). The 2024-05-02 expansion period may not be used to report CMS117 for the 2024 performance period. As indicated in known issue EKI-27, specific to 2024 reporting of the PCV20 pneumococcal vaccine formulation, the ‘Pneumococcal Conjugate Vaccine’ value set (OID: 2.16.840.1.113883.3.464.1003.196.12.1221) does not include CVX code 216. To meet numerator requirements, implementers can either map PCV20 to the ‘pneumococcal vaccine, unspecified formulation’ (CVX code 109) or the ‘Pneumococcal Conjugate, unspecified formulation’ (CVX code 152), as a workaround. We are unable to update the published value set for 2024 reporting; however, please note that CVX code 216 is included in the published value set for 2025 reporting.

      For the 2024 performance period, you must use the 2023-05-04 expansion version. The expansion versions' naming convention follows the year the value sets and codes are published.
      Show
      Thank you for your inquiry regarding CMS117v12 (Childhood Immunization Status). The 2024-05-02 expansion period may not be used to report CMS117 for the 2024 performance period. As indicated in known issue EKI-27 , specific to 2024 reporting of the PCV20 pneumococcal vaccine formulation, the ‘Pneumococcal Conjugate Vaccine’ value set (OID: 2.16.840.1.113883.3.464.1003.196.12.1221) does not include CVX code 216. To meet numerator requirements, implementers can either map PCV20 to the ‘pneumococcal vaccine, unspecified formulation’ (CVX code 109) or the ‘Pneumococcal Conjugate, unspecified formulation’ (CVX code 152), as a workaround. We are unable to update the published value set for 2024 reporting; however, please note that CVX code 216 is included in the published value set for 2025 reporting. For the 2024 performance period, you must use the 2023-05-04 expansion version. The expansion versions' naming convention follows the year the value sets and codes are published.
    • CMS0117v12
    • We are failing the measure because the measure does not recognize doses of PCV20 (CVX 216) as fulfilling the need for a pneumococcal vaccine.

      On 2024-05-02, a new value set was published which includes CVX 216. 

      [May 2024 Release eCQM & Hybrid Measure Value Sets Publication Date: May 02, 2024

      https://vsac.nlm.nih.gov/download/ecqm?rel=20240502]

      However, on the downloads page it appears under the dropdown for "2025 Reporting/Performance Period of eCQM & Hybrid Measure Value Sets"

      QUESTION#1: Why was the expansion not published as an update under the "2024 Reporting/Performance Period of eCQM & Hybrid Measure Value Sets"? 

      QUESTION#2: Can we nonetheless report CMS117 for measurement year 2024 using the 2024-05-02 expanded value set?

      Thanks.

            edave Mathematica EC eCQM Team
            dbarshain David Bar-Shain, MD (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            5 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: